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Abstract
Background: Despite the existence of various published studies regarding the effects of tobacco smoking on
pregnancy, and especially in regards to placental blood flow and vascular resistance, some points still require
clarification. In addition, the amount of damage due to tobacco smoking exposure that occurs has not been
quantified by objective means. In this study, we looked for a possible association between flow resistance indices
of several arteries and the levels of urinary cotinine and the concentration of carbon monoxide in the exhaled air
(COex) of both smoking and non-smoking pregnant women. We also looked for a relationship between those
findings and fetal growth and birth weight.
Methods: In a prospective design, thirty pregnant smokers and thirty-four pregnant non-smokers were studied.
The volunteers signed consent forms, completed a self-applied questionnaire and were subjected to Doppler
velocimetry. Tobacco smoking exposure was quantified by subject provided information and confirmed by the
measurement of urinary cotinine levels and by the concentration of carbon monoxide in the exhaled air (COex).
The weight of newborns was evaluated immediately after birth.
Results: Comparing smoking to non-smoking pregnant women, a significant increase in the resistance index was
observed in the uterine arteries (P = 0.001) and umbilical artery (P = 0.001), and a decrease in the middle cerebral
artery (P = 0.450). These findings were associated with progressively higher concentrations of COex and urinary
cotinine. A decrease in the birth weight was also detected (P < 0.001) in association with a progressive increase in
the tobacco exposure of the pregnant woman.
Conclusions: In pregnant women who smoke, higher arterial resistance indices and lower birth weights were
observed, and these findings were associated with increasing levels of tobacco smoking exposure. The values were
significantly different when compared to those found in non-smoking pregnant women. This study contributes to
the findings that smoking damage during pregnancy is dose-dependent, as demonstrated by the objective
methods for measuring tobacco smoking exposure.
Background
Evidence regarding the negative effects of tobacco smok-
ing on fetal development is widely documented in exist-
ing literature. The toxic effects vary from perinatal
complications, such as low birth weight, to changes in
adult behavior [1-5].
Regarding the effects of maternal tobacco smoking on
placental blood flow and vascular resistance, there still
exists some controversy regarding which vessels are
most affected and if the effects are acute or chronic [6].
However, most studies quantify smoking only by the
self-report of subjects, a method that is frequently not
reliable. It is known that smokers sometimes provide
false information about their smoking status, and among
pregnant women, the percentage of misreporting is
unknown. This occurs especially if the individual is
under pressure to quit smoking and thus a bias towards
a socially desirable response may occur [7-9].
T h ep r e v a l e n c eo fp a t i e n t sw h os t a t et h e ya r en o t
smoking anymore when, in fact, they actually still do
varies between 3% and 10% [9,10]. Abstinence during
smoking cessation treatment needs to be confirmed by
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been introduced in clinical practice [9,10].
The carbon monoxide concentration in exhaled air
(COex) is the most frequently used marker [10]. It is
affordable and measured by a non invasive technique
that provides immediate and reliable results [11]. It has
been widely used at smoking cessation centers in most
countries including Brazil [12-14].
The salivary, plasmatic and urinary cotinine concen-
trations are considered to be the golden standard for
objective evidence, but measurements require expertise
[9], are expensive and are not for clinical practice [15].
Doppler velocimetry in Obstetrics is used to measure
blood flow in the uterine arteries, and it characterizes
the blood flow from the mother to the fetus. When the
blood flow is studied in the fetal middle cerebral artery,
it shows the flow in fetal brain. There are tables with
established values that are considered normal. The
methodology has already been standardized and we have
followed such guidelines in this study.
This study aimed to search for a relationship among
resistance indices of the uterine, umbilical and middle
cerebral fetal arteries via Doppler velocimetrical ultraso-
nographic evaluation and smoking habits measured
through objective methods (cotinine concentration and
COex). The relationship between smoking and fetal
growth and with birth weight was also examined.
Our primary objective was to assess whether there is a
proportional change in vascular resistance as quantita-
tive exposure to smoking during pregnancy increases.
The hypothesis is that smoking reduces the maternal-
fetal blood flow related to increased tobacco smoking
and effects fetal growth.
Methods
Using a prospective cohort design study, 30 pregnant
smokers and 34 pregnant non-smokers were recruited
between September 2008 and September 2009 from the
Low Risk Prenatal Care Center of the Obstetric Depart-
ment at the Hospital Sao Lucas da Pontificia Universi-
dade Catolica do Rio Grande do Sul (HSL-PUCRS) in
Porto Alegre, Brazil.
The inclusion criteria were: pregnant women between
18 and 35 years of age, in the third trimester of gesta-
tion (dated in the first trimester), regularly receiving
prenatal care, had no gestational complaints and agreed
t op a r t i c i p a t ei nt h es t u d yb ys i g n i n gt h ec o n s e n tf o r m .
The exclusion criteria were: ultrasonographic diagnosis
of fetal malformations, clinical situations related to the
pregnancy or any other disease that could interfere with
fetal growth, illiteracy, psychiatric disorders, alcoholism,
former smokers and the possibility to move to another
city and to lose contact during the study. Patients who
discontinued prenatal care and those that stopped or
started smoking during their pregnancy were also
excluded. No patient was excluded after inclusion in the
study because no patient discontinued the follow up
during the prenatal period.
Smoking was determined according to the report of
using cigarettes from the periconceptional period to the
day of the interview. The periconceptional period was
defined as the period starting one month before the
date of the last menstruation. To be considered a non-
smoker, patients must have stated that they had never
smoked, especially during their pregnancy, and reports
were confirmed by a biochemical marker.
All patients were submitted to same tests to confirm
their smoking status: concentration of carbon monoxide
in the exhaled air and concentration of urinary cotinine.
We found no discrepancy, that is, no patient who said
was a non-smoker was detected as a smoker.
At the initial medical visit, the objectives of the study
were explained and the consent form signature was
obtained.
Next, a standardized questionnaire was completed,
pregnancy and smoking data were collected and the
COex measurement was performed. A urine sample was
also collected to measure cotinine levels, and an ultraso-
nograph examination was performed. Smoking between
the tests was not permitted. After the birth, patient was
contacted to collect data about the newborn one month
after delivery.
Doppler velocimetry exam with colored mapping of
the uterine arteries, umbilical arteries and fetal medium
cerebral arteries was performed with an Ultrasonix
machine (Sonix Model, Version 2.5, Ultrasonix Medical
Corporation, Canada), and the resistance indices (RI)
were recorded. We also recorded the amniotic fluid
index, the placental grade, fetal biometry and the esti-
mated fetal weight placed on a percentile curve for the
gestational age to adjust for possible bias.
To decrease possible bias at ultrasonography due to a
large variability of Doppler values, three measurements
were taken, and the mean was recorded.
COex was measured by a MicroCO Meter (MicroCO -
Micro Medical Ltd., Rochester, Kent, UK) using an elec-
trochemical sensor. Patients were instructed to breathe
deeply, hold their breath for 20 seconds and then to
exhale slowly and completely through a mouthpiece.
Smokers had COex measured no more than two hours
after their last smoked cigarette [9].
For measurement of the cotinine concentration in the
urine, a previously-validated high performance liquid
chromatography (HPLC) method was used [16].
Whereas the ultrasonography examinations and the
exhaled CO measurements were performed by the same
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cian blind to patient study group.
Mean ± SD were used to describe the symmetric, con-
tinuous data and the median and range was used for
asymmetric data. A percentile calculation was used for
categorical data. Student’s t test and ANOVA were used
to compare means. Adjustments for potential confound-
ing effects were made by covariance analysis (ANCOVA)
and multiple linear regression. Possible confounding fac-
tors included in the analysis for adjustment were patient
age, gestational age, degree of placenta, amniotic fluid
index, number of pregnancies. The assigned level of sig-
nificance was 0.05. The data were processed by the Statis-
tical Package for the Social Sciences (SPSS) Version 17.0
Patients were divided into four groups according to
the levels of COex (Group1: 0 ppm; Group 2: 1-4 ppm;
Group 3: 5-9 ppm; Group 4: ≥10 ppm) in order to analyze
possible changes in the resistance indices. The same ana-
lyses were also performed according to the levels of urin-
ary cotinine (Group 1: 0 ng/mL; Group 2: <50 ng/mL;
Group 3: 50-500 ng/mL; Group 4 >500 ng/mL).
We used percentiles to compare the resistance indices
and fetal birth weights according to the gestational age
of each patient. For weight, a Hadlock table was used
[17]. Analysis of the resistance index values was per-
formed by using the published standards for the respec-
tive percentiles [17].
The study was approved by the PUCRS Research
Ethics Committee, under No. 08/04319 on May
09
th 2008.
Results
Thirty pregnant smokers and 34 pregnant non-smokers
women were included in this study analysis. No signifi-
cant difference was observed between the two groups in
regards to age, amniotic fluid index, cultural and social
status, number of prior miscarriages or placenta grade.
Smokers had a greater number of pregnancies and
births than non-smokers, with values of 3.0 [95%CI 3.0-
11.0] vs. 2.0 [95%CI 1.0-5.0] p = 0,04; 1.5 [95% CI 0.0-
7.0] vs. 1.0 [0.0 - 4.0] p = 0,04 respectively (Table 1).
W h e nt h ee n t i r eg r o u po fn o ns m o k e r sw a ss t u d i e d ,
the RI in both uterine arteries (right uterine 37.3 ± 20.0
vs. 58.0 ± 23.0 p = 0.0010; left uterine 38.9 ± 17.6 vs.
56.1 ± 19.6 p = 0.001) and the umbilical artery (43.0 ±
19.0 vs.65.0 ± 15.0 p = 0.001) were higher compared to
smokers. The RI in the middle cerebral artery was lower
(45.00 ± 15.00 vs.36.3 ± 21.0 p = 0.450), but, the differ-
ence was not statistically significant (Table 2).
When the participants were grouped according to
COex levels (Group1 to Group 4), progressively higher
RI values were observed for the right uterine (Group 1:
36.2 ± 21.8, Group 2: 46.9 ± 20.3, Group 3: 44.4 ± 28.9,
Group 4: 66.5 ± 17.5 , p < 0.001) and left uterine
arteries (Group 1: 39.5 ± 18.9, Group 2: 40.5 ± 16.8,
Group 3: 52.8 ± 19.5, Group 4: 66.1 ± 16.7, p < 0.001)
and the umbilical artery (Group 1: 44.5 ± 21.3, Group 2:
49.1 ± 17.9, Group 3: 61.1 ± 13.1, Group 4: 71.1 ± 16.2,
p < 0.001) as the mean COex increased. In addition, we
observed lower RI values of the middle cerebral artery
(Group 1: 46.4 ± 14.3, Group 2: 42.1 ± 17.1, Group 3:
47.2 ± 19.5, Group 4: 27.7 ± 22.2, p < 0.001) as COex
increased (Table 3).
When analyzing the increasing values of urinary coti-
nine in the four groups of smokers, a statistically signifi-
cant progressive increase of the resistance indices for
the left uterine artery (p = 0.037) and the umbilical
artery (p < 0.001) were also identified. Although not sta-
tistically significant, the same trend was observed for the
right uterine artery p = 0.267 (Table 4). There was,
however, a decreasing trend for the RI of the middle
cerebral artery related to an increasing concentration of
urinary cotinine. This finding was statistically significant
in the linear regression, but the significance was not
maintained when adjusting for the possible confounding
factors described above.
Table 1 Characteristics of the sample according to
smoking habits
Non smokers
n=3 4
Smokers
n=3 0
P
Characteristics
Age 27.6 ± 6.1 27.3 ± 5.2 0.82
Pregnancies 2.0
[1 a 5]
3.0
[3 a 11]
0.04
Parities 1.0
[0 a 4]
1.5
[0 a 7]
0.04
Abortions 0.0
[0 a 3]
0.0
[0a3 ]
0.62
AFI 14.0 ± 2.0 13.3 ± 2.8 0.21
Placenta grade 1 (56%)
[0 a 2]
1(70%)
[0 a 3]
0.31
Data are presented as mean ± SD or median [minimum and maximum]. AFI:
amniotic fluid index. Age (years), pregnancies, abortions and parities
(number), Amniotic Fluid Index(cm), Placenta grade percent type I (As
classification Granumm)
17. P: statistical significance.
Table 2 Percentile of RI among pregnant women
according to smoking habits
Non smokers
n=3 4
Smokers
n=3 0
P
RI Percentile
RUA 37.3 ± 20.0 58.0 ± 23.0 0.001
LUA 38.9 ± 17.6 56.1 ± 19.6 0.001
UA 43.0 ± 19.0 65.0 ± 15.0 0.001
MCA 45.0 ± 15.0 36.3 ± 21.0 0.450
Data are presented as mean ± SD. P: statistical significance.
RUA: right uterine artery, LUA: left uterine artery,UA: umbilical artery, MCA:
middle cerebral artery. RI: vascular resistance index.
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percentile of the fetal birth weight in relation to
increased mother’sC O e xa sw e l la si n c r e a s e du r i n a r y
cotinine values ( p = 0.007).
Discussion
This study showed that the resistance indices of the pla-
cental vascular bed tended to rise with a quantitative
increase in tobacco smoking exposure measured by
objective methods in a dose-dependent effect. As far as
we know, this is the first report showing such dose-
effect through objective measurements of tobacco smok-
ing exposure.
Smoking women were classified according to progres-
sively increasing levels of COex to look for an associa-
tion of those concentrations with an increase in
resistance indices. Indeed, an increase in COex levels
was associated to an increase RI of the uterine and
umbilical arteries and a decrease in the resistance of the
middle cerebral artery. These findings were all statisti-
cally significant, even after adjusting for possible con-
founding factors.
When the groups were analyzed according to increas-
ing values of urinary cotinine, another marker of tobacco
exposure tested in this study, significant increases were
also observed in the left uterine and umbilical arteries.
The right uterine artery showed a trend towards an
increased RI, however, not statistically significant. The
middle cerebral artery showed a tendency towards a
decreased resistance related to the increasing cotinine
measurements, not statistically significant.
Smoking during pregnancy is known to influence or
even determine low birth weight and it is the main pre-
ventable cause of restricted intrauterine growth and
small size for gestational age [18]. Our findings are in
accordance of previous reports, showing that as a
Table 3 Percentile of RI and of birth weight between four groups according to carbon monoxide exhaled
concentration
COex
0 ppm
n=2 1
COex
1-4p p m
n=2 1
COex
5-9p p m
n=9
COex
≥ 10 ppm
n=1 3
P
[1] P
[2]
RI Percentile
RUA 36.2 ± 21.8
[10 a 90]
46.9 ± 20.3
[10 a 75]
44.4 ± 28.9
[10 a 90]
66.5 ± 17.5
[25 a 90]
0.003 <0.001
LUA 39.3 ± 18.7
[25 a 75]
40.5 ± 16.8
[25 a 75]
52.8 ± 19.5
[25 a 75]
66.1 ± 16.7
[50 a 95]
<0.001 <0.001
UA 44.5 ± 21.3
[10 a 75]
49.1 ± 17.9
[5 a 75]
61.1 ± 13.1
[50 a 75]
71.1 ± 16.2
[50 a 95]
0.001 <0.001
MCA 46.4 ± 14.3
[25 a 75]
42.1 ± 17.1
[5 a 75]
47.2 ± 19.5
[25 a 75]
27.7 ± 22.2
[5 a 75]
0.022 <0.001
Percentile of birth weight 49.05 ± 22.7
[10 a 90]
49.90 ± 25.8
[3 a 90]
41.2 ± 25.3
[3 a 75]
25.1 ± 16.6
[3 a 50]
0.017 <0.001
Data are represented as mean ± SD [minimum, maximum]. COex: concentration of carbon monoxide in the exhaled air, RI: vascular resistance index, RUA: right
uterine artery, LUA: left uterine artery, UA: umbilical artery, MCA: middle cerebral artery. P: statistical significance, [1]: variance analysis - ANOVA - oneway, [2]:
linear tendency obtained in regression model.
Table 4 Percentile of RI and of birth weight between four groups according to urinary cotinine levels
Cotinine
0
ng/mL
n=3 0
Cotinine
< 50 ng/mL
n=1 0
Cotinine
50 - 500 ng/mL
n=1 4
Cotinine
>500 ng/mL
n=1 0
P
[1] P
[2]
RI Percentile
RUA 42.8 ± 22.8
[10 a 90]
40.0 ± 25.7
[10 a 90]
55.3 ± 23.5
[10 a 90]
22.9 ± 22.9
[25 a 75]
0.201 0.267
LUA 41.1 ± 20.8
[25 a 95]
42.5 ± 20.6
[25 a 75]
58.9 ± 15.8
[25 a 75]
52.5 ± 18.4
[25 a 75]
0.033 0.037
UA 46.8 ± 20.1
[5 a 75]
46.0 ± 21.0
[10 a 75]
63.5 ± 14.6
[50 a 90]
68.5 ± 17.3
[50 a 95]
0.003 0.001
MCA 45.3 ± 15.7
[5 a 75]
42.5 ± 16.8
[25 a 75]
36.8 ± 21.8
[5 a 75]
34.5 ± 23.8
[5 a 75]
0.321 0.14
Percentile of birth weight 45.6 ± 21.5
[3 a 90 ]
62.4 ± 24.4
[25 a 90]
36.6 ± 24.0
[3 a 90]
27.1 ± 22.8
[3 a 75]
0.006 0.007
Data are represented as mean ± SD [minimum, maximum]. RI: vascular resistance index, RUA: right uterine artery, LUA: left uterine artery, UA: umbilical artery,
MCA: middle cerebral artery. P: statistical significance, [1]: variance analysis - ANOVA - oneway, [2]: adjusted for age, number of pregnancies and AFI in ANCOVA
model.
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decrease amount of blood and oxygen transported to
the fetus resulted in lower weights of the newborns.
This study contributes to those reports showing that it
is probably a dose-dependent effect. We found that
decreased birth weights correlated with increase in
tobacco smoking exposure, confirmed by both exposure
methods, urinary cotinine and COex.
A pattern of maternal-fetal perfusion with characteris-
tics of chronic hypoxia among the pregnant smokers
was observed. Those findings were similar to the centra-
lization phenomenon [19], with an increase in the RI of
the umbilical artery and a decrease in RI of the middle
cerebral artery. Thus, we infer that the fetus of a smok-
ing mother, as a consequence of the decreased placental
blood flow and possible tissue hypoxia, compensates
with tendency towards centralization of the blood flow.
Although the details of these circulatory adjustments
and their mechanisms are incomplete, it is likely that
when the partial pressure of O2 decreases and that of
CO2 increases above a certain level, the aortic and caro-
tid chemoreceptors are activated. This probably is the
mechanism that regulates the central vasodilatory
response to guarantee adequate oxygenation to the fetal
brain [20].
Prior studies [6,19,21,22] already studied the repercus-
sions of smoking on maternal-fetal flow, but all have
used patients’ self-report to quantify tobacco smoking
exposure. As mentioned previously, data reported by
smoking patients are not always reliable, what might
justify the heterogeneity of the results found in those
studies [23].
Albuquerque and colleagues [19] compared 74 preg-
nant smokers with 69 controls, classifying then accord-
ing to smoking status as informed by the patients. They
concluded that chronic maternal smoking was associated
with the increasing resistance of the uterine, umbilical
and fetal middle cerebral arteries. Other studies [20,21]
evaluated the cigarette acute effects. Kimya et al. [6]
studied 22 pregnant smokers and 21 non-smokers by
measuring Pulsatility Index, Resistance Index and Sys-
tole/Diastole of the uterine and umbilical before and
after smoking a cigarette default. They found no signifi-
cant change in the Doppler that could be attributed to
the acute effect of cigarette smoking, but all indices
were significantly higher in the smoking group com-
pared with the control group both before and after
cigarette smoking. They conclude that chronic smoking
caused an increase in vascular resistance of the placenta
and umbilical cord.
One of the strengths of this study is that the smoking
status of the patients were confirmed by biochemical
quantitative measurements (concentration of exhaled
CO and of cotinine in a urine sample), showing a
possible dose-effect of tobacco smoking exposure on
maternal-fetal blood perfusion.
Our results may be used as a tool for helping pregnant
smokers to stop or at least to decrease their tobacco
exposure by emphasizing that the risks to the fetus
occur in a dose-dependent manner. Our objective data
demonstrate that a higher smoking level results in
greater hemodynamic effects on the fetus. These effects
culminate in growth restriction that may have multiple
effects throughout the life of children.
Conclusions
In this study, using Doppler velocimetry in uterine,
umbilical and middle cerebral arteries flow, changes in
resistance indeces were detected comparing smoking to
non smoking pregnant women. A dose-dependent effect
in placental blood flow was found such that resistance
indices increased in accordance with increasing levels of
tobacco smoking exposure.
In addition, we found a decrease in fetal birth weight
that also correlated with an increase in measurements of
COex and urinary cotinine.
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